Vanda Pharmaceuticals Inc.
VNDA
$4.36
$0.051.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.21M | -29.49M | -4.91M | -5.32M | -4.52M |
| Total Depreciation and Amortization | 2.02M | 1.98M | 1.97M | 1.97M | 1.97M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.39M | -3.72M | 404.00K | -1.58M | 235.00K |
| Change in Net Operating Assets | 15.32M | -1.91M | 718.00K | -9.64M | -4.61M |
| Cash from Operations | -15.25M | -33.15M | -1.82M | -14.58M | -6.93M |
| Capital Expenditure | -299.00K | -436.00K | -214.00K | -161.00K | -1.63M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.97M | 44.34M | 4.21M | 12.22M | -13.63M |
| Cash from Investing | -15.27M | 43.90M | 3.99M | 12.06M | -15.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -425.00K | -409.00K | -155.00K | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -915.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -425.00K | -1.32M | -155.00K | -- | -- |
| Foreign Exchange rate Adjustments | 134.00K | 49.00K | -202.00K | 68.00K | -15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.81M | 9.48M | 1.82M | -2.46M | -22.21M |